Form 4: NeuroOne Medical Technologies Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 906 shares of common stock on March 31, 2025, to cover tax obligations.
Summary
- On March 31, 2025, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 906 shares of common stock.
- The transaction was executed at a price of $0.8502 per share.
- This disposal was conducted to cover tax obligations related to equity compensation.
- Following the transaction, Mertens directly owns 163,141 shares of NeuroOne Medical Technologies Corp.
- The transaction was reported on April 2, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects a routine transaction to cover tax obligations. It doesn't indicate any significant positive or negative outlook for the company.
Industry Context
This is a routine transaction for executives to cover tax obligations related to stock-based compensation. It doesn't necessarily reflect a change in the executive's confidence in the company.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of transaction: Steve Mertens disposed of 906 shares of common stock. |
| 04/02/2025 | Date of Form 4 filing. |
Keywords
NeuroOne Medical Technologies, NMTC, Steve Mertens, Chief Technology Officer, Form 4, Stock Sale, Tax Obligations, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.